<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04534010</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-55153</org_study_id>
    <secondary_id>BRS0117</secondary_id>
    <nct_id>NCT04534010</nct_id>
  </id_info>
  <brief_title>Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts</brief_title>
  <official_title>A Single Arm, Single Center Pilot Study Evaluating the Safety and Healing Time of a Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Graft</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate safety and healing time after nipple-areolar complex&#xD;
      (NAC) reconstruction with the BioAesthetics' decellularized human nipple-areolar complex&#xD;
      (dcl-hNAC) graft in patients who have had autologous breast reconstruction for breast cancer.&#xD;
      Secondary objectives will be to assess patient satisfaction, patient well-being, patient&#xD;
      self-esteem, patient body image, patient psychological well-being, nipple dimensions and&#xD;
      sensitivity following NAC reconstruction surgery with the BioAesthetics' dcl-hNAC graft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2021</start_date>
  <completion_date type="Anticipated">April 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to healing of implanted NACgraft</measure>
    <time_frame>14 months</time_frame>
    <description>Time to healing for each NACgraft will be as the first weekly visit at which the surgeon and central reviewer deem the graft &gt;99% epithelialized. This measurement will be reported as the number of weeks to healing. Degree of healing will be based on visual assessment by the surgeon and central reviewer with the following metrics on a visual analog scale (VAS): epithelialization (0-100%); granulation (0-100%); overall healing (0-100%). Photographs will be taken using a standardized 3d imaging device, stored and transmitted securely to a central reviewer for independent review. Time to complete healing will be defined as the first visit at which the surgeon and independent reviewer determine that there is &gt;99% epithelialization of the graft.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>NACgraft patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>uni- or bilateral engraftment surgery will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NACgraft</intervention_name>
    <description>Patients requiring reconstruction of their nipple and areola have a NACgraft surgically implanted on their breasts. A NACgraft is a novel decellularized cadaveric implant derived from human nipples.</description>
    <arm_group_label>NACgraft patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient age 18-65&#xD;
&#xD;
          -  Patient desires NAC grafting â‰¥3 months after autologous breast reconstruction&#xD;
&#xD;
          -  Patient agrees to sleep on back until grafts healed (6 weeks)&#xD;
&#xD;
          -  Patient agrees to abstain from aspirin, alcohol, or excessive caffeine until grafts&#xD;
             healed (6 weeks)&#xD;
&#xD;
          -  Patient agrees to not undergo NAC tattooing until completing study (12 months)&#xD;
&#xD;
          -  Patient is able to understand and willing to sign informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of delayed wound healing&#xD;
&#xD;
          -  history of Vitamin C deficiency&#xD;
&#xD;
          -  history of diabetes (Type I or Type II)&#xD;
&#xD;
          -  current BMI&lt;18.5 or &gt;40 kg/m,&#xD;
&#xD;
          -  patient has any other uncontrolled comorbidity.&#xD;
&#xD;
          -  Patient has a history of allergic reaction to any decellularized biologic matrix&#xD;
             product.&#xD;
&#xD;
          -  Patient is currently smoking or using tobacco or nicotine products (i.e. patch, gum,&#xD;
             or nasal spray) or has used such products in the past 12 months.&#xD;
&#xD;
          -  Patient is currently receiving radiation or chemotherapy or received radiation to the&#xD;
             breast wall.&#xD;
&#xD;
          -  Patient has a history of prior NAC reconstruction&#xD;
&#xD;
          -  Patient has had NAC tattooing.&#xD;
&#xD;
          -  Patient is pregnant, breastfeeding or planning to become pregnant during the study&#xD;
             period.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geoffrey C Gurtner</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford Universiy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shannon Meyer</last_name>
    <phone>650-724-1953</phone>
    <email>smeyer27@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Meyer</last_name>
      <phone>650-724-1953</phone>
      <email>smeyer27@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Geoffrey C Geoffrey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 20, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Geoffrey C. Gurtner</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

